IL31 and primary cutaneous T-cell non-Hodgkin lymphoma: Therefore, at the start of our study, we hypothesized that serum samples from the more pruritic variants of CTCL (FMF and SS) and from more advanced stages of disease express differentially higher IL31 serum levels.